Topline Phase 2 Results from Ongoing LPCN 1144 Lift Study in Biopsy-Confirmed Nash Subjects
We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.